PDCD10 and glioblastoma: As supporting data, overexpression of PDCD10 increased the sensitivity of GBM cells to TMZ in the treatment phase (Figure 3B) and significantly suppressed the regrowth activity of GBM cells in the post-treatment phase (Figure 3C).